This webcast discusses the latest MDD pharmacotherapies and best practices for incorporating tools that support effective patient-provider communication and relationship-building in MDD management.
This webcast discusses best practices for incorporating recently approved DMTs, guideline updates and clinical/pharmacoeconomic data into value-based benefit design and formulary discussions.
This webcast discusses the development of system-wide comprehensive CVD care practices for patients with T2D based on cardiovascular outcomes trials data.
This webcast discusses tranforming the quality of IBS-D management through a targeted model of care that addresses the individualized needs and symptomology of patients.
This webcast examines clinical evidence surrounding the mechanisms of action, efficacy, and tolerability of new and emerging pharmacotherapies, including combination therapies, for UI management.